Basilea Pharmaceutica
BSLN.SW
#6322
Rank
A$0.98 B
Marketcap
$81.46
Share price
0.00%
Change (1 day)
18.96%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2023: A$19.45 Million

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are A$0.18 Billion. In 2023 the company made an earning of A$19.45 Million a decrease over its 2022 earnings that were of A$20.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2023

Annual earnings

Year Earnings Change
2023A$19.45 M-5.02%
2022A$20.48 M-276.18%
2021-A$11.63 Million-55.31%
2020-A$26.02 Million-28%
2019-A$36.13 Million-27.06%
2018-A$49.54 Million62.13%
2017-A$30.56 Million-60.94%
2016-A$78.21 Million-19.67%
2015-A$97.36 Million48.25%
2014-A$65.68 Million12.95%
2013-A$58.15 Million-35.16%
2012-A$89.68 Million-5.75%
2011-A$95.15 Million-152.57%
2010A$0.18 B-199.59%
2009-A$0.19 Billion-15.54%
2008-A$0.22 Billion22.84%
2007-A$0.18 Billion60.07%
2006-A$0.11 Billion85.69%
2005-A$58.94 Million-43.04%
2004-A$0.11 Billion47.04%
2003-A$70.37 Million-34.82%
2002-A$0.11 Billion